Last reviewed · How we verify
malignancy
Approved treatments
- Fludeoxyglucose F-18 · Downstate Clincl
Fludeoxyglucose F-18 is a radioactive sugar molecule that accumulates in cells with high metabolic activity, allowing for visualization of cancer and other conditions. - Fludeoxyglucose F-18 · 3D Imaging Drug
Fludeoxyglucose F-18 is a radioactive molecule that accumulates in areas of high metabolic activity, allowing for imaging of various conditions. - Technetium Tc 99M Sestamibi · Cyclomedica
Technetium Tc 99m Sestamibi accumulates in viable myocardial tissue similar to thallous chloride TI-201, with possible mitochondrial retention.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- malignancy patent landscape — cliff calendar, originator estates, attackable patents
- malignancy treatment landscape brief
- malignancy treatment updates RSS
Frequently asked questions about malignancy
What drugs treat malignancy?
Tracked treatments include Fludeoxyglucose F-18, Technetium Tc 99M Sestamibi.
What is the treatment for malignancy?
Standard treatment for malignancy includes Fludeoxyglucose F-18, Technetium Tc 99M Sestamibi. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: malignancy patent cliff · malignancy CI report
- Treatment: Fludeoxyglucose F-18 · Downstate Clincl
- Treatment: Fludeoxyglucose F-18 · 3D Imaging Drug
- Treatment: Technetium Tc 99M Sestamibi · Cyclomedica
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing